BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23644712)

  • 1. Recurrence of mediastinal node cancer after lobe-specific systematic nodal dissection for non-small-cell lung cancer.
    Maniwa T; Okumura T; Isaka M; Nakagawa K; Ohde Y; Kondo H
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):e59-64. PubMed ID: 23644712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lobe-Specific Lymph Node Dissection as a Standard Procedure in Surgery for Non-Small Cell Lung Cancer: A Propensity Score Matching Study.
    Adachi H; Sakamaki K; Nishii T; Yamamoto T; Nagashima T; Ishikawa Y; Ando K; Yamanaka K; Watanabe K; Kumakiri Y; Tsuboi M; Maehara T; Nakayama H; Masuda M
    J Thorac Oncol; 2017 Jan; 12(1):85-93. PubMed ID: 27553515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.
    Lardinois D; Suter H; Hakki H; Rousson V; Betticher D; Ris HB
    Ann Thorac Surg; 2005 Jul; 80(1):268-74; discussion 274-5. PubMed ID: 15975380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extent of removal for mediastinal nodal stations for patients with clinical stage I non-small cell lung cancer: effect on outcome.
    Jeon HW; Moon MH; Kim KS; Kim YD; Wang YP; Park HJ; Park JK
    Thorac Cardiovasc Surg; 2014 Oct; 62(7):599-604. PubMed ID: 24420680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of lobe-specific mediastinal lymphadenectomy versus systematic mediastinal lymphadenectomy for clinical stage T₁a N₀ M₀ non-small cell lung cancer.
    Ma W; Zhang ZJ; Li Y; Ma GY; Zhang L
    J Cancer Res Ther; 2013 Sep; 9 Suppl 2():S101-5. PubMed ID: 24135239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes of thoracoscopic lobectomy for patients with clinical N0 and pathologic N2 non-small cell lung cancer.
    Zhong C; Yao F; Zhao H
    Ann Thorac Surg; 2013 Mar; 95(3):987-92. PubMed ID: 23261117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is video-assisted thoracoscopic surgery a feasible approach for clinical N0 and postoperatively pathological N2 non-small cell lung cancer?
    Watanabe A; Mishina T; Ohori S; Koyanagi T; Nakashima S; Mawatari T; Kurimoto Y; Higami T
    Eur J Cardiothorac Surg; 2008 May; 33(5):812-8. PubMed ID: 18342533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of selective lymph node dissection based on patterns of lobe-specific lymph node metastases on patient outcome in patients with resectable non-small cell lung cancer: a large-scale retrospective cohort study applying a propensity score.
    Ishiguro F; Matsuo K; Fukui T; Mori S; Hatooka S; Mitsudomi T
    J Thorac Cardiovasc Surg; 2010 Apr; 139(4):1001-6. PubMed ID: 19733863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lobe-specific Lymph Node Dissection in Clinical Stage IA Solid-dominant Non-small-cell Lung Cancer: A Propensity Score Matching Study.
    Zhao Y; Mao Y; He J; Gao S; Zhang Z; Ding N; Xue Q; Gao Y; Wang D; Zhao J; Tan F; Yuan L; Li F; Wang S; Yang L
    Clin Lung Cancer; 2021 Mar; 22(2):e201-e210. PubMed ID: 33187913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lobe-specific mediastinal nodal dissection is sufficient during lobectomy by video-assisted thoracic surgery or thoracotomy for early-stage lung cancer.
    Shapiro M; Kadakia S; Lim J; Breglio A; Wisnivesky JP; Kaufman A; Lee DS; Flores RM
    Chest; 2013 Nov; 144(5):1615-1621. PubMed ID: 23828253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes?
    Kudo Y; Saji H; Shimada Y; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Eur J Cardiothorac Surg; 2012 Sep; 42(3):414-9. PubMed ID: 22398463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective mediastinal lymphadenectomy for clinico-surgical stage I non-small cell lung cancer.
    Okada M; Sakamoto T; Yuki T; Mimura T; Miyoshi K; Tsubota N
    Ann Thorac Surg; 2006 Mar; 81(3):1028-32. PubMed ID: 16488715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic lymph node staging practice and stage-predicted survival after resection of lung cancer.
    Osarogiagbon RU; Allen JW; Farooq A; Berry A; O'Brien T
    Ann Thorac Surg; 2011 May; 91(5):1486-92. PubMed ID: 21524460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of different mediastinal lymphadenectomy on clinical-stage IA non-small cell lung cancer].
    Ma K; Wang TY; He BL; Chang D; Gong M
    Zhonghua Wai Ke Za Zhi; 2008 May; 46(9):670-3. PubMed ID: 18956719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Appropriate extent of lymph node dissection for clinical I a stage non-small cell lung cancer].
    Pan TC; Zheng Z; Li J; Chen T; Liu LG; Wei X
    Ai Zheng; 2007 Mar; 26(3):303-6. PubMed ID: 17355796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Video-assisted thoracic surgery systematic mediastinal nodal dissection and stage migration: impact on clinical pathway.
    Amer K; Khan AZ; Singh N; Addis B; Jogai S; Harden S; Peebles C; Brown I
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1474-81. PubMed ID: 21497109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is lobe-specific lymph node dissection appropriate in lung cancer patients undergoing routine mediastinoscopy?
    Turna A; Solak O; Kilicgun A; Metin M; Sayar A; Gürses A
    Thorac Cardiovasc Surg; 2007 Mar; 55(2):112-9. PubMed ID: 17377865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete thoracic mediastinal lymphadenectomy leads to a higher rate of pathologically proven N2 disease in patients with non-small cell lung cancer.
    Cerfolio RJ; Bryant AS; Minnich DJ
    Ann Thorac Surg; 2012 Sep; 94(3):902-6. PubMed ID: 22776083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lobe-Specific Nodal Dissection for Clinical Stage I and II NSCLC: Japanese Multi-Institutional Retrospective Study Using a Propensity Score Analysis.
    Hishida T; Miyaoka E; Yokoi K; Tsuboi M; Asamura H; Kiura K; Takahashi K; Dosaka-Akita H; Kobayashi H; Date H; Tada H; Okumura M; Yoshino I;
    J Thorac Oncol; 2016 Sep; 11(9):1529-37. PubMed ID: 27249959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is systemic node dissection for accuracy staging in clinical stage I non-small cell lung cancer worthwhile in the elderly?
    Iwasaki A; Hamatake D; Hamanaka W; Hamada T; Shirakusa T; Yamamoto S; Shiraishi T
    Thorac Cardiovasc Surg; 2008 Feb; 56(1):37-41. PubMed ID: 18200466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.